FDA Test-Drives New Risk-Benefit Framework
In a shift that could benefit drugmakers, the U.S. Food and Drug Administration is testing a new method for weighing the safety risks of a new pharmaceutical against its potential benefits,...To view the full article, register now.
Already a subscriber? Click here to view full article